Melrose Industries Plc Given Buy Rating at Liberum Capital (MRO)
Melrose Industries Plc (LON:MRO)‘s stock had its “buy” rating reiterated by analysts at Liberum Capital in a research report issued to clients and investors on Thursday. They currently have a GBX 330 ($5.46) price objective on the stock. Liberum Capital’s price target suggests a potential upside of 17.21% from the company’s current price.
Shares of Melrose Industries Plc (LON:MRO) opened at 278.20 on Thursday. Melrose Industries Plc has a 52 week low of GBX 246.70 and a 52 week high of GBX 382.20. The stock has a 50-day moving average of GBX 266.7 and a 200-day moving average of GBX 283.5. The company’s market cap is £2.982 billion.
A number of other firms have also recently commented on MRO. Analysts at Investec raised their price target on shares of Melrose Industries Plc from GBX 325 ($5.38) to GBX 330 ($5.46) in a research note on Thursday. They now have a “buy” rating on the stock. Separately, analysts at RBC Capital reiterated an “outperform” rating on shares of Melrose Industries Plc in a research note on Tuesday. They now have a GBX 330 ($5.46) price target on the stock. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of Melrose Industries Plc in a research note on Tuesday, August 12th. They now have a GBX 330 ($5.46) price target on the stock. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of GBX 326.50 ($5.40).
Melrose PLC operates through three divisions: Energy, Lifting and Other Industrial. The Energy segment incorporates the Turbogenerators (LON:MRO) and Marelli business units, specialist suppliers of energy industrial products to the worldwide market.
Receive News & Ratings for Melrose Industries Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Melrose Industries Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.